The most important financial indicators for the company Hipo Med Srl - Unique Identification Number 18417990:
sales in 2023 was
744.510
euro, registering a net profit of
195.190
euro and having an average number of
15
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta stomatologica having the NACE code 8623.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 2.6%, from 727.840 euro in the year 2022, to 744.510 euro in 2023.
The Net Profit decreased by -56.467 euro, from 252.423 euro in 2022, to 195.190 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Hipo Med Srl - CUI 18417990
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
291.158
289.172
452.721
629.952
845.141
471.983
450.182
528.508
495.364
456.875
Current Assets
13.978
13.710
12.435
44.751
26.056
16.220
9.273
9.641
80.095
67.291
Inventories
4.711
4.074
2.805
22.854
2.858
178
1.243
0
742
7.209
Receivables
8.118
8.883
7.699
10.257
15.557
4.007
3.588
4.243
4.992
6.868
Cash
1.150
753
1.930
11.641
7.641
12.035
4.442
5.397
74.361
53.214
Shareholders Funds
12.748
18.112
46.374
72.477
285.388
188.395
237.969
293.877
277.516
280.928
Social Capital
3.391
3.420
3.385
9.895
9.713
9.525
9.344
9.137
9.166
9.138
Debts
292.389
284.771
418.782
602.548
586.964
300.610
221.877
244.463
298.725
243.238
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8623 - 8623"
CAEN Financial Year
8623
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
67.291 euro in 2023 which includes Inventories of
7.209 euro, Receivables of
6.868 euro and cash availability of
53.214 euro.
The company's Equity was valued at
280.928 euro, while total Liabilities amounted to
243.238 euro.
Equity increased by 4.253 euro, from 277.516 euro in 2022, to 280.928 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Hipo Med Srl